Allied Corp Files for Full Psilocybin Patent for Psilonex™ Rx Pharmaceutical KELOWNA, British Columbia, March 16, 2022 (GLOBE NEWSWIRE) -- Allied Corp. ("Allied" or the “Company”) (OTCQB: ALID) is pleased to announce that it has successfully filed for a full patent regarding...

Allied Corp. Advances Psilocybin Product Psilonex™ RX and Initiates Manufacturing Process KELOWNA, British Columbia, Sept. 10, 2021 (GLOBE NEWSWIRE) -- Allied Corp. ("Allied" or the “Company”) (OTCQB: ALID) is pleased to announce that it has initiated the manufacturing activities for...

Allied Corp Increases Intellectual Property Protection by Filing Trademark for Pharma Product PSILONEX KELOWNA, British Columbia, March 25, 2021 (GLOBE NEWSWIRE) -- Allied Corp. ("Allied" or the “Company”) (OTCQB: ALID) an international medical company focused on creating and providing health...